Ark Genomic Revolution ETF (ARKG) |
|
46.69 -1.33 (-2.77%)
|
01-26 00:17 |
|
Open: |
46.75 |
Pre. Close: |
48.02 |
|
High:
|
48.05 |
Low:
|
45.47 |
|
Volume:
|
6,181,071 |
Market Cap:
|
0M |
|
|
|
|
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
48.186 - 48.453 |
48.453 - 48.67 |
|
Low:
|
44.668 - 45.035 |
45.035 - 45.334 |
|
Close:
|
46.139 - 46.695 |
46.695 - 47.146 |
|
Technical analysis |
as of: 2022-01-25 4:22:12 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 66.77 One year: 76.91 |
| Support: |
Support1: 43.12 Support2: 35.88 |
| Resistance: |
Resistance1: 57.17 Resistance2: 65.85 |
| Pivot: |
51.80 |
| Moving Average: |
MA(5): 47.37 MA(20): 54.24
MA(100): 68.69 MA(250): 80.47 |
| MACD: |
MACD(12,26): -4.20 Signal(9): -3.66 |
| Stochastic oscillator: |
%K(14,3): 13.84  %D(3): 7.62 |
| RSI: |
RSI(14): 28.78 |
| 52-week: |
High: 115.15 Low: 43.12 Change(%): -54.2 |
| Average Vol(K): |
3-Month: 3985 10-Days: 5279 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.ARKG has closed above bottom band by 18.0%. Bollinger Bands are 49.2% wider than normal. The large width of the bands suggest high volatility as compared to Ark Genomic Revolution ETF's normal range. The bands have been in this wide range for 10 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Mon, 24 Jan 2022
Short Bets Against Cathie Wood's ETFs Suggest More Pain Ahead - Bloomberg
Thu, 20 Jan 2022
Thursday's ETF Movers: ARKG, QVML - Nasdaq
Wed, 19 Jan 2022
7 Best Biotech ETFs to Buy - WTOP
Tue, 11 Jan 2022
Pfizer/Beam Deal Highlights In Vivo Potential - Nasdaq
Fri, 31 Dec 2021
Biotech bundles can reduce risk - The Spokesman-Review
Thu, 30 Dec 2021
Insiders Bullish on Certain Holdings of ARKG - Nasdaq
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Neutral |
Discounted cash flow: |
Neutral |
| Return on Assets: |
Neutral |
Price to Earnings: |
Neutral |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
